AU Patent

AU2006283846B2 — Pyrazine derivatives and use as PI3K inhibitors

Assigned to Merck Serono SA · Expires 2012-04-05 · 14y expired

What this patent protects

The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, pl…

USPTO Abstract

The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006283846B2
Jurisdiction
AU
Classification
—
Expires
2012-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Merck Serono SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.